拉巴胺素诱导的胰岛素抵抗是由mTORC2损失介导的,并且与长寿无关
Dudley W Lamming1, Lan Ye, Pekka Katajisto
1Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
概括
拉帕米辛通过抑制mTORC1延长寿命,但通过破坏mTORC2.2损害葡萄糖耐受性. 这项研究揭示了mTORC2中断中介的拉帕米辛.
科学领域:
- 生物遗传学 生物遗传学
- 分子生物学分子生物学
- 代谢研究研究 代谢研究
背景情况:
- 众所周知,一种mTORC1抑制剂Rapamycin可以在不同物种中延长寿命.
- 卡路里限制可以改善胰岛素敏感性和寿命,被认为涉及mTORC1抑制.
- 矛盾的是,慢性拉巴胺素治疗会损害葡萄糖耐受性和胰岛素作用,这表明超出mTORC1.1.的复杂效应.
研究的目的:
- 研究拉帕米对葡萄糖平衡的矛盾作用背后的机制.
- 确定mTORC2在调解拉帕米辛在体内作用中的作用.
- 为了将mTORC1抑制的延长寿命效应与代谢干扰脱而出.
主要方法:
- 使用小鼠模型进行体内研究.
- 评估葡萄糖耐受性和胰岛素作用.
- 基因操纵来改变mTORC1和mTORC2的信号传输.
主要成果:
- 拉帕米辛在体内破坏了mTORC2.
- mTORC2对于胰岛素抑制肝脏葡萄糖生成至关重要.
- 仅仅减少mTORC1信号传递就会延长寿命,而不会影响葡萄糖平衡.
结论:
- mTORC2的干扰是拉帕米对葡萄糖代谢的不良影响的关键媒介.
- 通过mTORC1抑制延长寿命可以独立于代谢副作用.
- 这项研究阐明了mTORC1和mTORC2在衰老和新陈代谢中的不同作用.
更多相关视频
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
05:28A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction
Published on: August 27, 2019
相关概念视频
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Regulation of the Unfolded Protein Response
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
